Marshall Wace’s Sensus Healthcare SRTS Stock Holding History

Marshall Wace’s Portfolio SRTS Stock Details SRTS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-46,962	Closed	-$222K	–	3144
2025 Q1	$222K	Sell	46,962 -85,324	-64%	-$497K	﹤0.01%	2368
2024 Q4	$915K	Buy	132,286 +65,994	+100%	+$484K	﹤0.01%	1774
2024 Q3	$384K	Sell	66,292 -11,095	-14%	-$67.4K	﹤0.01%	2024
2024 Q2	$412K	Buy	77,387 +46,732	+152%	+$215K	﹤0.01%	2034
2024 Q1	$116K	Buy	+30,655	New	+$111K	﹤0.01%	2295
2022 Q3	–	Sell	-67,633	Closed	-$519K	–	3769
2022 Q2	$519K	Sell	67,633 -64,074	-49%	-$538K	﹤0.01%	2774
2022 Q1	$1.33M	Sell	131,707 -64,067	-33%	-$585K	﹤0.01%	2311
2021 Q4	$1.41M	Buy	+195,774	New	+$1.07M	﹤0.01%	2277

Other funds holding SRTS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

PRCP

Pacific Ridge Capital Partners Lake Oswego, Oregon $462M AUM 40.76% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

DSCM

Divisadero Street Capital Management Miami, Florida $2.39B AUM 134.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

PCM

Perritt Capital Management Chicago, Illinois $59.8M AUM 26.94% 1-Year Est. Return

Marshall Wace's SRTS Position: Q2 2025 in Review

Marshall Wace sold out of Sensus Healthcare (SRTS) in Q2 2025, closing a stake of 46,962 shares — an estimated $222K sold.

Marshall Wace first reported a position in SRTS in Q4 2021 and held it in 8 quarters. The position peaked at $1.41M in Q4 2021. 46 funds tracked by Wall St. Rank hold SRTS as of Q2 2025.

Marshall Wace reported no remaining Sensus Healthcare position as of Q2 2025 after selling out during the quarter.
Marshall Wace sold 46,962 Sensus Healthcare shares in Q2 2025, an estimated $222K.
Marshall Wace first reported a position in Sensus Healthcare in Q4 2021 and held it in 8 quarters.
Marshall Wace's Sensus Healthcare position peaked at $1.41M in Q4 2021.
46 funds tracked by Wall St. Rank held Sensus Healthcare as of Q2 2025.

Based on Marshall Wace's 13F filing for Q2 2025, filed 13 Aug 2025.